<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="t0002" orientation="portrait" position="float">
 <label>Table 2.</label>
 <caption>
  <p>
   <italic>In vitro</italic> pharmacokinetic properties of the seven selected TU derivatives (
   <italic>n</italic> = 2).
  </p>
 </caption>
 <!--OASIS TABLE HERE-->
 <table frame="hsides" rules="groups">
  <colgroup>
   <col width="80pt"/>
   <col width="80pt"/>
   <col width="80pt"/>
   <col width="80pt"/>
   <col width="80pt"/>
   <col width="80pt"/>
  </colgroup>
  <thead>
   <tr>
    <th align="left"> </th>
    <th align="center">Metabolic 
     <break/>Stability
     <sup>a</sup>
     <break/>(t
     <sub>1/2</sub>, min)
    </th>
    <th align="center">Plasma stability
     <sup>b</sup>
     <break/>(% after 4 h)
    </th>
    <th align="center">PAMPA permeability
     <sup>c</sup>
     <break/>(Log Pe, cm/s)
    </th>
    <th align="center">CYP3A4
     <break/>IC
     <sub>50</sub>
     <sup>d</sup>
     <break/>(μM)
    </th>
    <th align="center">CYP2C9
     <break/>IC
     <sub>50</sub>
     <sup>e</sup>
     <break/>(μM)
    </th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td align="center">J2H-1701</td>
    <td align="center">&gt;60</td>
    <td align="char" char=".">86.8</td>
    <td align="char" char=".">−5.95</td>
    <td align="center">&gt;100</td>
    <td align="center">&gt;100</td>
   </tr>
   <tr>
    <td align="center">HCV-2577</td>
    <td align="center">&gt;60</td>
    <td align="char" char=".">91.5</td>
    <td align="center">ND</td>
    <td align="center">&gt;10</td>
    <td align="center">&gt;40</td>
   </tr>
   <tr>
    <td align="center">HCV-2602</td>
    <td align="center">&gt;60</td>
    <td align="char" char=".">67.0</td>
    <td align="char" char=".">−7.44</td>
    <td align="center">&gt;10</td>
    <td align="center">&gt;40</td>
   </tr>
   <tr>
    <td align="center">HCV-2614</td>
    <td align="center">&gt;60</td>
    <td align="char" char=".">110</td>
    <td align="char" char=".">−6.95</td>
    <td align="center">&gt;10</td>
    <td align="center">&gt;40</td>
   </tr>
   <tr>
    <td align="center">HCV-2694</td>
    <td align="center">&gt;60</td>
    <td align="char" char=".">131</td>
    <td align="char" char=".">−8.26</td>
    <td align="center">&gt;10</td>
    <td align="center">&gt;40</td>
   </tr>
   <tr>
    <td align="center">HCV-3083</td>
    <td align="center">&gt;60</td>
    <td align="char" char=".">86.9</td>
    <td align="char" char=".">−5.90</td>
    <td align="center">6.79</td>
    <td align="center">&gt;10</td>
   </tr>
   <tr>
    <td align="center">HCV-3149</td>
    <td align="center">&gt;60</td>
    <td align="char" char=".">97.2</td>
    <td align="char" char=".">−5.17</td>
    <td align="center">7.42</td>
    <td align="center">&gt;10</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="TF1">
   <label>
    <sup>a</sup>
   </label>
   <p>Metabolic stability in human liver microsomes at 1 μM. LC-MS/MS detection.</p>
  </fn>
  <fn id="TF2">
   <label>
    <sup>b</sup>
   </label>
   <p>Stability in human plasma at 1 μM. LC-MS/MS detection.</p>
  </fn>
  <fn id="TF3">
   <label>
    <sup>c</sup>
   </label>
   <p>Compound permeability measured using parallel artificial membrane permeability assay at 1 μM. LC-MS/MS detection.</p>
  </fn>
  <fn id="TF4">
   <p>
    <sup>d</sup>
    <sup>,</sup>
    <sup>e</sup>Measured using CYP specific probe substrates in human liver microsomes. LC-MS/MS detection.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
